Series B - Alcyone Lifesciences
Investment Firm
Overview
Alcyone Lifesciences develops a platform of technology that optimizes molecular therapy for the brain.
Announced Date
Jan 15, 2014
Funding Type
Series B
Highlights
Location
United States, North America
Social
Investor Lead
Participant Investors
2
| Investor Name |
|---|
 Harbor Light Capital Partners |
 Edgar Jannotta |
Round Details and Background
Alcyone Lifesciences raised $4000000 on 2014-01-15 in Series B
Alcyone Lifesciences develops a platform of technology that optimizes molecular therapy for the brain.
Company Funding History
5
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Dec 24, 2015 |  Venture Round - Alcyone Lifesciences | - | 3.6M | |
| Jan 15, 2014 | Series B - Alcyone Lifesciences | 2 | - | 4.0M |
| May 09, 2013 | Venture Round - Alcyone Lifesciences | - | 1.0M | |
| Mar 28, 2012 | Series A - Alcyone Lifesciences | - | 1.8M |
Recent Activity
There is no recent news or activity for this profile.